°­Àǽð£ Àå¼Ò Title Lecturer
18:00~20:00 A room Bone - Recent advances in bone formation ÁÂÀå : ±è¿ë±â, Àӽ±æ
How PTHrP regulates growth plate chondrocytes Kronenberg,
Harvard Univ., USA
Thyroid hormone regulation of IGF-1 action during pre-pubertal growth Mohan,
Loma Linda Univ., USA
Requirement of Osterix for adult bone formation and maintenance ±èÁ¤Àº, °æºÏÀÇ´ë
B room Neuroendocrine ÁÂÀå : ±è¼±¿ì
Surgical strategies for the various types of pituitary adenomas Shozo Yamada,
Toranomon Hospital, Japan
Outcomes of the medical treatment of Acromegaly John Wass,
Oxford Univ., UK
20:00~ A room Àú³á ¸¸Âù
°­Àǽð£ Àå¼Ò Title Lecturer
08:00~08:40 µî·Ï
08:40~10:10 °­ÀÇ½Ç 1 Updated Clinical Guideline ÁÂÀå : Á¶Á¤±¸, ¹é¼¼Çö
Is A1C Useful for Diabetes Screening, Diagnosis in Clinical Practice? ¿ÀÁö¿µ, ÀÌÈ­ÀÇ´ë
The Altered Adrenal Axis and Treatment With Glucocorticoids During Critical Illness ±èÇý¼ø, °è¸íÀÇ´ë
When HDL-Cholesterol Isn't Enough: Assessing Options for Managing Residual Risk ±èÇüÁø, °üµ¿ÀÇ´ë
°­ÀÇ½Ç 2 Çп¬»ê ½ÉÆ÷Áö¾ö I - ÁÁÀº¿¬±¸¸¦ À§ÇÑ ÀÇ·áÀ±¸®¿Í ¿¬±¸»ç¾÷ÀÇ ÀÌÇØ ÁÂÀå: À¯ÇüÁØ, ¹Úż±
»ç¶÷À» ´ë»óÀ¸·Î ÇÏ´Â ¿¬±¸À±¸® ±è¿ÁÁÖ, ¼­¿ïÀÇ´ë ÀÇ»çÇб³½Ç
¿¬±¸ÀÚÀÇ ±Û¾²±â À±¸® ÀÌÀÎÀç, ¼­¿ï±³´ë
³»ºÐºñ ¿¬±¸ÀÚ¸¦ À§ÇÑ ±¹Ã¥¿¬±¸ºñ ¼Ò°³ (¿¬±¸ºñ Á¾·ù¿Í °èȹ¼­ ÀÛ¼º) ÀÌÀαÔ, °æºÏÀÇ´ë
°­ÀÇ½Ç 3 ½Å°æ³»ºÐºñ¿¬±¸È¸ ½ÉÆ÷Áö¾ö ÁÂÀå : ¹éÀÚÇö
Molecular targeted therapies for pituitary tumor ±¸Ã¶·æ, ¿¬¼¼ÀÇ´ë
Cushing¡¯s disease management after surgery ±è»ó¿Ï, ¼­¿ïÀÇ´ë
Insulin status in acromegaly patients after sandostatin treatment ±è¼º¿î, °æÈñÀÇ´ë
10:10~10:30 Coffee Break
10:30~12:00 °­ÀÇ½Ç 1 Diabetes & Obesity I - Hepatic insulin resistance ÁÂÀå : ÀÌÇü¿ì, Â÷ºÀ¼ö
Hepatic insulin resistance vs. Peripheral insulin resistance ÃÖö¼ö, °¡ÃµÀÇ´ë
°£Á¶Á÷°ú ¸»ÃÊ Àν¶¸°°¨¼ö¼º Á¶Á÷ »çÀÌ communication ÀÌ´ëÈ£, Á¦ÁÖÀÇ´ë
Hepatic insulin resistanceÀÇ Ä¡·á ±èöÈñ, ¼øõÇâÀÇ´ë
°­ÀÇ½Ç 2 Çп¬»ê ½ÉÆ÷Áö¾ö ¥± - ³»ºÐºñ Á¾¾çÀÇ Áø´Ü ¹× »õ·Î¿î Ä¡·áÁ¦ ÁÂÀå: ±èµ¿¼±, ¹ÚµµÁØ
The Efficacy and safety of Pasireotide in Acromegaly and Cushing¡¯s syndrome ±è¹Î¼±, ¿ï»êÀÇ´ë
Medical treatment of pancreatic neuroendocrine tumor ÀåÈï¹®, ¿ï»êÀÇ´ë
Novel B-raf kinase inhibitor °³¹ß ½Éź¸, KIST
°­ÀÇ½Ç 3 ½Å°æ³»ºÐºñ¿¬±¸È¸ ½ÉÆ÷Áö¾ö ÁÂÀå : ±è¼º¿¬
Multidisciplinary treatment after primary surgery in acromegaly Shozo Yamada.
Toranomon Hospital, Tokyo, Japan
New insights in the management of GH deficiency ÀÌÀºÁ÷, ¿¬¼¼ÀÇ´ë
12:00~13:20 °­ÀÇ½Ç 1 Luncheon Lecture ¥° ÁÂÀå: ÀÌÇöö
Early Insulinization Á¤Àΰæ, °æÈñÀÇ´ë
Luncheon Lecture ¥± ÁÂÀå: ±èÅÂÈ­
New Paradigm of Antihypertensive Treatment : Initial Combination Therapy À¯±ÔÇü, °Ç±¹ÀÇ´ë ½ÉÀå³»°ú
13:20~13:30 °­ÀÇ½Ç 1 °³È¸»ç ´ëÇѳ»ºÐºñÇÐȸ ȸÀå ±è¿ë±â
13:30~14:20 °­ÀÇ½Ç 1 Plenary Lecture ¥° ÁÂÀå : ±è¼º¿î
A review of current and future treatment strategies of Non-functioning pituitary adenomas John Wass,
Oxford University, UK
14:20~15:50 °­ÀÇ½Ç 1 Bone I - Beyond bisphosphonates ÁÂÀå : °­¹«ÀÏ, Á¤È£¿¬
Denosumab and other developing drugs L. Fitzpatrick (GSK, USA)
Newly developing anabolic agents ¹é±âÇö, °¡Å縯ÀÇ´ë
Newly developing (reversible) anti-resorptives °íÁ¤¹Î, ¿ï»êÀÇ´ë
°­ÀÇ½Ç 2 Çп¬»ê ½ÉÆ÷Áö¾ö¥² - Drug discovery and development in endocrinology and metabolism ÁÂÀå: ¹Ú°æ¼ö, ¼Û¹ÎÈ£
´ç´¢º´ Ä¡·áÁ¦ÀÇ ÃÖ±Ù °³¹ßµ¿Çâ õÇý°æ,
°¡ÃµÀÇ´ë ¾à¸®Çб³½Ç
Drug discovery in metabolic syndrome: focus on adipokines Gary Sweeny,
Institut Pasteur Korea
°æ±¸¿ë Ç÷´ç°­ÇÏÁ¦ Á¦¹Ì±Û¸³Æ¾ÀÇ ¿¬±¸°³¹ß »ç·Ê ÀÓÇöÁÖ, LG»ý¸í°úÇÐ
°­ÀÇ½Ç 3 Health Care Professional Session I ÁÂÀå: ½É°­Èñ, ÃÖ±ÝÈñ
Àν¶¸° ÁÖ»ç¹ýÀÇ ½ÇÁ¦ ±èÇý·Ã, µ¿»êÀÇ·á¿ø
´ç´¢ÀÎÀÇ ¿îµ¿¿ä¹ý ±è¿µ¼÷, ºÎ»ê ¸Þ¸®³î º´¿ø
´ç´¢º´ÀÇ ÇÕº´Áõ °Ë»ç¹ý ¼Ûº¹·Ê, ¼­¿ï¼º¸ðº´¿ø
15:50~16:10 Coffee Break (Æ÷½ºÅÍ ±¸¿¬ ¹ßÇ¥- º»°ü 1Ãþ)
16:10~17:40 ¹«±ÃȭȦ(º°°ü 2Ãþ) Health Care Professional Session ¥± ÁÂÀå: Ãְ湬, ¼ÕÁ¤¹Î
Diet, Inflammation, and Diabetes ¼ÕÁ¤¹Î, ¿ø±¤´ë ½ÄÇ°¿µ¾çÇаú
³»ºÐºñÁúȯÇöȲ ¹× °ü·Ã¿äÀÎ : ±¹¹Î°Ç°­¿µ¾çÁ¶»ç°á°ú¸¦ Áß½ÉÀ¸·Î ¿À°æ¿ø,
Áúº´°ü¸®º»ºÎ ¸¸¼ºº´Á¶»ç°ú
´ç´¢ ¿¬±¸¿¡¼­ÀÇ ¿µ¾çÀ¯ÀüüÀû Á¢±Ù äÁö¼÷,
¿¬¼¼´ëÇб³ ³ëÈ­°úÇבּ¸¼Ò
°­ÀÇ½Ç 2 Çп¬»ê ½ÉÆ÷Áö¾ö¥³ - U-healthcare in Endocrinology ÁÂÀå: ÀåÇÐö, ·ùÁØ¿À
»óÈ£ ¿¬µ¿Àû À¯ÇコÄɾ ÀÌ¿ëÇÑ ´ç´¢º´ °ü¸® ¹× ½º¸¶Æ®ÄÉ¾î »ç¾÷ ¹ÚÁß¿­, ¿ï»êÀÇ´ë
Application of ubiquitous healthcare service using new medical information system in elderly diabetic patients ÀÓ¼ö, ¼­¿ïÀÇ´ë
À¯Çコ ¼­ºñ½º ÇöȲ ¹× À̽´ ¾È½ÃÈÆ, ºñÆ®ÄÄÇ»ÅÍ
Biosensors for U-Healthcare Á¤ºÀÇö, KRIBB
°­ÀÇ½Ç 3 Thyroid I - Graves ophthalmopathy ÁÂÀå : ÀÌ»ó¿­ , ±Ã¼º¼ö
º´ÀÎ ¹× ±âŸ ÃÖ½ÅÁö°ß Hiromatsu Yuji,
Kurume Univ., JPN
½ÇÇèÀû Ä¡·á À±Áø¼÷, ¿¬¼¼ÀÇ´ë
¾È°ú ¼ö¼úÀû Á¢±Ù ÃÖÈñ¿µ, ºÎ»êÀÇ´ë
17:40~ °­ÀÇ½Ç 1 Welcome reception
°­Àǽð£ Àå¼Ò Title Lecturer
07:30~08:00 °­ÀÇ½Ç 1 Breakfast Lecture ÁÂÀå: ±è¼º¿î
The role of DPP-4 inhibitors in individualized strategies to control diabetes Á¶¿µ¹Î, ¼­¿ïÀÇ´ë
08:00~08:30 µî·Ï
08:30~10:00 °­ÀÇ½Ç 1 Meet the Expert
DM & Obesity ¿ìÁ¤ÅÃ, °æÈñÀÇ´ë
Adrenal ÃÖµ¿¼·, °í·ÁÀÇ´ë
Endocrine Hypertension À̹®±Ô, ¼º±Õ°üÀÇ´ë
°­ÀÇ½Ç 2 Thyroid II - Thyroid cancer ÁÂÀå : Á¶º¸¿¬, ¼Û¿µ±â
Epigenetic dysregulation in thyroid cancer Tetsuo Kondo, Yamanashi Univ., JPN
(18)F-FDG Uptake and Biological Markers in Thyroid Cancer ±èÀÎÁÖ, ºÎ»êÀÇ´ë
°©»ó¼± ¾Ï¼¼Æ÷¸¦ ÀÌ¿ëÇÑ ¾ÏÀüÀÌ ¿¬±¸ ¸ðµ¨ ±¸Ãà ±èÅ¿ë, ¿ï»êÀÇ´ë
°­ÀÇ½Ç 3 Bone II - Anabolic signals: Parathyroids and IGFs ÁÂÀå : ½ÅÂù¼ö, ÃÖÁ¦¿ë
Role of Ephrins in the regulation of bone formation S. Mohan ,
Loma Linda Univ., USA
PTH and SOST ÀÌÀ¯¹Ì, ¿¬¼¼ÀÇ´ë
Hypoparathyroidism and GCMB À̽ÃÈÆ, °¡ÃµÀÇ´ë
10:10~10:20 Coffee Break
10:20~11:10 °­ÀÇ½Ç 1 Plenary Lecture ¥± ÁÂÀå : Àӽ±æ
Actions of PTH on bone H. Kronenberg
(Harvard Univ., USA)
11:10~12:40 °­ÀÇ½Ç 1 Updated Clinical Guideline ÁÂÀå : Á¶¿ë¿í, ¼ÕÇö½Ä
Guidelines on Management of Primary Aldosteronism Issued ±è»ó¼ö, ºÎ»êÀÇ´ë
Current Issues Guidelines on Hormone Therapy ±è¼ºÈÆ, ¿ï»êÀÇ´ë »êºÎÀΰú
Endocrine Emergencies - thyroid storm, myxedema coma, DKA, and adrenal crisis ·ù¿ÁÇö, ÇѸ²ÀÇ´ë
°­ÀÇ½Ç 2 Diabetes & Obesity II - Stem cell therapy in diabetic vascular complications ÁÂÀå : À̸í½Ä, À±°ÇÈ£
Mesenchymal stem cell therapy for lower extremity ischemia ±èº´¼ö, ¼­¿ï°ø´ë
Ç÷°ü³»ÇÇ Àü±¸¼¼Æ÷¸¦ ÀÌ¿ëÇÑ ´ç´¢º´¼º Á·ºÎ±Ë¾ç Ä¡·á ±Ç»ó¸ð, CHAÀÇ°úÇдëÇб³
Stem cell therapy in ischemic cardiovascular disease ÀÓµµ¼±, °í·ÁÀÇ´ë
°­ÀÇ½Ç 3 Vascular biology ÁÂÀå : ±èÀÎÁÖ, À¯¼øÁý
Intravenous Endothelial-like Cells Differentiated from Mesenchymal Stem Cells Accelerate Reendothelialization in Balloon-injured Rat Ȳ±âö, ¿¬¼¼ÀÇ´ë
Homing and differentiation of endothelial progenitor cell ±Ç¿µ±Ù, ¿¬¼¼´ë
Establishment of endothelial stem cells from embryonic stem cells °í±Ô¿µ, KAIST
12:40~14:00 °­ÀÇ½Ç 1 Luncheon Lecture ¥² ÁÂÀå: ±è±¤¿ø
Tredaptive, Novel Approach for Comprehensive Lipid Management ¹Úö¿µ, ¼º±Õ°üÀÇ´ë
Luncheon Lecture ¥³ ÁÂÀå: ±èµÎ¸¸
Will ACCORD Trial Results Change Your BP and Lipid Goals for Diabetics? ±è½Å°ï, °í·ÁÀÇ´ë
14:00~14:30 °­ÀÇ½Ç 1 Presidential Lecture
°©»ó¼±¾ÏÀÇ Áø´Ü ¹× Ä¡·á¿¡¼­ ÇÙÀÇÇÐÀÇ ÀÌ¿ë ±è¿ë±â,
´ëÇѳ»ºÐºñÇÐȸ ȸÀå
14:30~15:10 °­ÀÇ½Ç 1 2010³âµµ ³²°îÇмú»ó ½Ã»ó ¹× ¹ßÇ¥ ÁÂÀå : ¹ÎÇå±â
Emerging role of Autophagy in Pancreatic - cell Homeostasis and Diabetes À̸í½Ä, ¼º±Õ°üÀÇ´ë
15:10~15:20 °­ÀÇ½Ç 1 2010 ±¹³»/¿Ü Çмú»ó ½Ã»ó½Ä, ÇϹݱ⠱¹Á¦ÇÐȸ Áö¿ø±Ý ¼ö»óÀÚ ½Ã»ó½Ä
15:20~15:50 °­ÀÇ½Ç 1 Ư°­ ÁÂÀå : ¼Û¿µ±â
°©»ó¼±°áÀýÀÇ Áø´Ü ¹× Ä¡·á°¡À̵å¶óÀÎ ¿øÀڷº´¿ø ÀÌ°¡Èñ
15:50~17:20 °­ÀÇ½Ç 1 Meet the Expert
Bone ¹Î¿ë±â, ¼º±Õ°üÀÇ´ë
Pituitary º¯µ¿¿ø, ¼øõÇâÀÇ´ë
Thyroid ¼Û¹ÎÈ£, Ãæ³²ÀÇ´ë
°­ÀÇ½Ç 2 Vascular imaging - Imaging of atherosclerosis ÁÂÀå : ±èµÎ¸¸, ÀÌÀºÁ÷
MRI imaging of atherosclerosis Çã¿ë¹Î, SIRIC
Peptide Probe-Based Targeted Imaging of Atherosclerosis À̺´Çå, °æºÏÀÇ´ë
CT imaging of atherosclerosis ÃÖº´¿í, ¿¬¼¼ÀÇ´ë
°­ÀÇ½Ç 3 Aging and endocrine change ÁÂÀå : ¿ìÁ¤ÅÃ, °í°æ¼ö
Aging, sarcopenia and diabetes ¹Ú¼®¿ø, CHAÀÇ°úÇдëÇб³
Aging and osteoporosis ¿À±â¿ø, ¼º±Õ°üÀÇ´ë
Aging and changes in somatotropic axis ±èµ¿¼±, ÇѾçÀÇ´ë
17:20~ °­ÀÇ½Ç 1 Dinner Lecture ÁÂÀå: ±è¼º¿î
What is the optimal treatment for obese type 2 DM patients after OAD? ±è¼º·¡, °¡Å縯ÀÇ´ë
Æóȸ»ç ´ëÇѳ»ºÐºñÇÐȸ ÀÌ»çÀå Àӽ±æ
°­Àǽð£ Àå¼Ò Title Lecturer
08:00~08:25 µî·Ï
08:25~08:30 °­ÀÇ½Ç 1 °³È¸»ç ±è¿ë±â,
´ëÇѳ»ºÐºñÇÐȸ ȸÀå
08:30~10:10 °­ÀÇ½Ç 1 °ñ´Ù°øÁõÀÇ Áø·á ÁÂÀå : ±è¿ë±â,
´ë±¸½Ã ³»°ú°³¿øÀÇ ÇùÀÇȸ ȸÀå ¹Ú½ÃÈ­
08:30-08:50 1. °ñ´Ù°øÁõ Áø´Ü ±â±âÀÇ ÃÖ½ÅÁö°ß ¾ç½Â¿À, µ¿³²±Ç¿øÀÚ·ÂÀÇÇпø
08:50-09:10 2. °ñ´Ù°øÁõ °ü·Ã °Ë»ç(°ñ´ë»çÁöÇ¥, Ä®½·, ºñŸ¹ÎD, È£¸£¸ó ¹× ±âŸ) ¿À±â¿ø, ¼º±Õ°üÀÇ´ë
09:10-09:30 3. °ñ´Ù°øÁõ Ä¡·á ¾àÁ¦ÀÇ ÃÖ½ÅÁö°ß ±è´öÀ±, °æÈñÀÇ´ë
09:30~09:50 4. °ñ´Ù°øÁõ ȯÀÚ Áø·á¿Í ¾àÁ¦ ó¹æ ½ÇÁ¦ Áõ·Ê Á¤À±¼®, ¾ÆÁÖÀÇ´ë
09:50-10:10 ÁúÀÇ, ÀÀ´ä ¹× ÅäÀÇ(5ºÐ)
10:10~10:30 Coffee Break
10:30~12:30 °­ÀÇ½Ç 1 °©»ó¼±Áúȯ(Ç×ÁøÁõ, ÀúÇÏÁõ, °©»ó¼±Á¾, °áÀý)ÀÇ Ä¡·á ÁÂÀå : ±Ã¼º¼ö, ±è¿ø¹è
10:30-10:40 1. °©»ó¼± Ç÷¾×°Ë»ç ¼³¸í ±èÅ¿ë, ¿ï»êÀÇ´ë
10:40-10:50 2. Ç×ÁøÁõ Ä¡·á¿¡ ÇÊ¿äÇÑ Áö½Ä°ú Æ÷ÀÎÆ® ±èº¸Çö, ºÎ»êÀÇ´ë
10:50-11:00 3. ÀúÇÏÁõ Ä¡·á¿¡ ÇÊ¿äÇÑ Áö½Ä°ú Æ÷ÀÎÆ® ½Åµ¿¿±, ¿¬¼¼ÀÇ´ë
11:00-11:10 4. °©»ó¼±Á¾°ú °áÀý ȯÀÚ¸¦ Áø·áÇÒ ¶§ °¡Àå ÇÊ¿äÇÑ Áö½Ä ÀÓµ¿ÁØ, °¡Å縯ÀÇ´ë
11:10-11:20 5. °©»ó¼±ÀÇ ÀüÇüÀûÀÎ ÃÊÀ½ÆÄ ¼Ò°ßµé ÃÖ¿µ½Ä, °í½ÅÀÇ´ë
11:20-11:35 6. °©»ó¼±ÀÇ ¾î·Á¿î Áõ·Ê ÀÌÇØÇϱ⠰­È£Ã¶, Àü³²ÀÇ´ë
11:35-12:30 ÁúÀÇ, ÀÀ´ä ¹× ÆгΠÅäÀÇ(55ºÐ) ÁÂÀå ¹× Æгθ®½ºÆ®: °­»ç 6ÀÎ(ÁöÁ¤)
12:30~13:30 °­ÀÇ½Ç 1 Luncheon Lecture ¥´
 
13:30~15:00 °­ÀÇ½Ç 1 ´ç´¢º´ÀÇ Áø´Ü, Ç÷´çÁ¶Àý, Àν¶¸° Åõ¿©, ÇÕº´Áõ ¿¹¹æ ÁÂÀå : ÀÌÇü¿ì, ¼Û¿µµæ
13:30-13:40 1. ´ç´¢º´ÀÇ ¿øÀÎÀû/ÀÓ»óÀû ºÐ·ù¿Í ÀÚ¿¬°æ°ú Ãְ湬, °í·ÁÀÇ´ë
13:40-13:50 2. °øº¹/½ÄÈÄÇ÷´ç, ´çÈ­Ç÷»ö¼Ò ¹× Ç÷´çº¯µ¿(Glycemic excursion) ±èÇüÁø, °üµ¿ÀÇ´ë
13:50-14:00 3. DPP4¾ïÁ¦Á¦¿Í GLP-1 À¯»çÁ¦ ÃÖ½ÅÁö°ß ±è°æ¾Æ, µ¿±¹ÀÇ´ë
14:00-14:15 4. °æ±¸¿ë ¾àÁ¦ ½ÃÀÛ, ¼±ÅÃ, Ãß°¡, Á¶ÇÕ ¹× º¯°æ ±èÀçÇö, ¼º±Õ°üÀÇ´ë
14:15-14:30 5. Àν¶¸° ÁÖ»çÀÇ ½ÃÀÛ, ¼±ÅÃ, È°¿ë ¹× ÁÖÀÇÁ¡ ³²È«¿ì, ±¹¸³Áß¾ÓÀÇ·á¿ø
14:30~14:45 6. ½Å°æº´ÁõÀÇ Æò°¡¿Í °ü¸®¹æ¹ý ¹× ¾àÁ¦Ã³¹æ ±è´ëÁß, ¾ÆÁÖÀÇ´ë
14:45~15:00 7. ´ç´¢º´È¯ÀÚÀÇ °íÇ÷¾Ð°ú °íÁöÇ÷Áõ ¾àÁ¦Ã³¹æ ±èÇý¼ø, °è¸íÀÇ´ë
15:00~15:20 Coffee Break
15:20~16:30 °­ÀÇ½Ç 1 ÁúÀÇ, ÀÀ´ä ¹× ÆгΠÅäÀÇ (60ºÐ) ÁÂÀå ¹× Æгθ®½ºÆ®: °­»ç 6ÀÎ(ÁöÁ¤)
16:30~16:40 °­ÀÇ½Ç 1 Æóȸ»ç Àӽ±æ,
´ëÇѳ»ºÐºñÇÐȸ ÀÌ»çÀå